JDVZX
Price
$16.95
Change
-$0.03 (-0.18%)
Updated
Oct 16 closing price
Net Assets
491.71M
RLBFX
Price
$39.04
Change
-$0.06 (-0.15%)
Updated
Oct 16 closing price
Net Assets
265.83B
Interact to see
Advertisement

JDVZX vs RLBFX

Header iconJDVZX vs RLBFX Comparison
Open Charts JDVZX vs RLBFXBanner chart's image
JPMorgan Diversified R6
Price$16.95
Change-$0.03 (-0.18%)
VolumeN/A
Net Assets491.71M
American Funds American Balanced R5
Price$39.04
Change-$0.06 (-0.15%)
VolumeN/A
Net Assets265.83B
JDVZX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
JDVZX vs. RLBFX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVZX is a Hold and RLBFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 266B vs. JDVZX (492M). JDVZX pays higher dividends than RLBFX: JDVZX (2.94) vs RLBFX (2.00). JDVZX was incepted earlier than RLBFX: JDVZX (8 years) vs RLBFX (23 years). JDVZX (0.70) is less costly to investors than RLBFX (0.29). JDVZX is a more actively managed with annual turnover of: 83.00 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than JDVZX: RLBFX (250) vs JDVZX (15000000). RLBFX annual gain was more profitable for investors over the last year : 9.05 vs. JDVZX (7.42). RLBFX return over 5 years is better than : 43.75 vs. JDVZX (8.77).
JDVZXRLBFXJDVZX / RLBFX
Total Expense Ratio0.580.29200%
Annual Report Gross Expense Ratio0.700.29241%
Fund Existence8 years23 years-
Gain YTD11.58814.77278%
Front LoadN/AN/A-
Min. Initial Investment150000002506,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets492M266B0%
Annual Yield % from dividends2.942.00147%
Returns for 1 year7.429.0582%
Returns for 3 years39.2052.7574%
Returns for 5 years8.7743.7520%
Returns for 10 yearsN/A78.54-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEAM150.130.29
+0.19%
Atlassian Corp
TDAC10.38N/A
N/A
Translational Development Acquisition Corp.
OPCH27.10-0.03
-0.11%
Option Care Health
NVRI12.41-0.03
-0.24%
Enviri Corp
ATMV11.50-0.29
-2.46%
AlphaVest Acquisition Corp